Uchino M, Hirano T, Uyama E, Hashimoto Y
Department of Neurology, Kumamoto University, Kumamoto 860-0811, Japan.
Ann N Y Acad Sci. 2002 Nov;977:273-8. doi: 10.1111/j.1749-6632.2002.tb04826.x.
We reviewed 12 patients from 11 Japanese families diagnosed as having CADASIL from 1998 to 2001. The age of onset of focal neurologic deficits ranged from 38 to 71 years (mean: 50.4 +/- 9.8 years). Japanese CADASIL patients rarely had migraine and frequently presented with symptoms of dementia at diagnosis. Notch3 mutations were concentrated in exons 3, 4, and 5. Cysteine was replaced by another amino acid or vice versa in the majority of Japanese CADASIL patients. However, in 2 families, the mutations were not related to cysteine. In the prospective study, 2030 patients with stroke were hospitalized in 6 hospitals with stroke units in the Kumamoto district from 1999 to 2001. Among them, 14 patients fulfilled the criteria of being less than 60 years of age, showing lacunar strokes and/or TIA, presence of a family history, and no risk factors of stroke. One of these 14 patients was diagnosed as having CADASIL by DNA analysis. However, if hyperlipidemia was excluded from the list, 16 patients fulfilled the criteria and 2 patients were diagnosed as having CADASIL by DNA analysis. It was suspected that the incidence of CADASIL is not so rare in Japan. There were some families with CADASIL-like features, but without Notch3 mutations or GOM, suggesting the need for genetic analysis in the future.
我们回顾了1998年至2001年期间来自11个日本家庭的12例被诊断为患有伴有皮质下梗死和白质脑病的常染色体显性遗传性脑动脉病(CADASIL)的患者。局灶性神经功能缺损的发病年龄在38岁至71岁之间(平均:50.4±9.8岁)。日本CADASIL患者很少有偏头痛,且在诊断时经常出现痴呆症状。Notch3突变集中在外显子3、4和5。在大多数日本CADASIL患者中,半胱氨酸被另一种氨基酸取代,反之亦然。然而,在2个家庭中,这些突变与半胱氨酸无关。在这项前瞻性研究中,1999年至2001年期间,熊本县6家设有卒中单元的医院收治了2030例卒中患者。其中,14例患者符合年龄小于60岁、表现为腔隙性卒中或短暂性脑缺血发作(TIA)、有家族史且无卒中危险因素的标准。这14例患者中的1例经DNA分析被诊断为患有CADASIL。然而,如果将高脂血症排除在标准之外,则有16例患者符合标准,其中2例经DNA分析被诊断为患有CADASIL。据推测,CADASIL在日本的发病率并非如此罕见。有一些具有CADASIL样特征但无Notch3突变或颗粒状嗜银物质(GOM)的家庭,这表明未来需要进行基因分析。